Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, effectiveness, and recommended dose of
Proxinium in North American patients with Squamous Cell Head and Neck Cancer